2023年

原著論文: 症例報告を含む

1.	Kimura Y, Shinoda M, Shinkai M, Kaneko T: Solithromycin inhibits IL-13-induced goblet cell hyperplasia and MUC5AC, CLCA1, and ANO1 in human bronchial epithelial cells. PeerJ, 11: e14695, 2023.
2.	Sakurai Y, Oshikata C, Katayama T, Takagi S, Kaneko Y, Yo K, Kaneko T, Kubota H, Matsubara T, Tsurikisawa N: A case of eosinophilic polyangiitis with granulomatosis that evolved to cardiac arrest due to advanced atrioventricular block. Nagoya J Med Sci, 85: 171-178, 2023.
3.	Fujii H, Hara Y, Saigusa Y, Tagami Y, Murohashi K, Nagasawa R, Aoki A, Izawa A, Seki K, Watanabe K, Horita N, Kobayashi N, Kaneko T: ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease. Can Respir J, 2023: 5088207, 2023.
4.	Nagasawa R, Hara Y, Murohashi K, Saigusa Y, Nishikawa Y, Tanaka M, Aoki A, Tagami Y, Kobayashi N, Kudo M, Kaneko T: Additional Efficacy of Macrolide for Patients With Acute Deterioration of Interstitial Lung Disease Requiring Corticosteroid Pulse Therapy. Am J Ther, 30: 170-173, 2023.
5.	Honda Y, Yoneda M, Kobayashi T, Iwaki M, Kawamura N, Nogami A, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Horita N, Saito S, Kaneko T, Nakajima A: Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease. Hepatol Res, 53: 219-227, 2023.
6.	Takayasu H, Kata Y, Otsu Y, Inoue S, Kaneko T: ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report. Cureus, 15: e36711, 2023.
7.	Watanabe K, Kobayashi N, Kaneko T: Recurrent Transient Asymptomatic Pulmonary Opacity with Long-Term Afatinib: A Case Report. Case Rep Oncol, 16: 167-171, 2023.
8.	Matsumoto H, Kobayashi N, Shinoda S, Goto A, Kaneko A, Fukuda N, Kamimaki C, Kubo S, Watanabe K, Horita N, Hara Y, Ishikawa Y, Kaneko T: Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan. Sci Rep, 13: 5208, 2023.
9.	Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Clinical features of asthma with connective tissue diseases. Clin Respir J, 17: 303-310, 2023.
10.	Hiro S, Teranishi S, Sawazumi T, Nagaoka S, Sugimoto C, Nagayama H, Segawa W, Kajita Y, Maeda C, Kubo S, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report. Thorac Cancer, 14: 1311-1315, 2023.
11.	Sugimoto C, Teranishi S, Sawazumi T, Nagaoka S, Nagayama H, Segawa W, Hiro S, Kajita Y, Maeda C, Kubo S, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Primary tracheal small-cell carcinoma detected 11 months after surgery for pulmonary large-cell neuroendocrine carcinoma: A case report. Thorac Cancer, 14: 1212-1216, 2023.
12.	Masumoto N, Oshikata C, Nakadegawa R, Motobayashi Y, Osada R, Manabe S, Kaneko T, Tsurikisawa N: Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis. Allergy Asthma Clin Immunol, 19: 40, 2023.
13.	Fukuda N, Horita N, Kaneko A, Goto A, Kaneko T, Ota E, Kew KM: Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 6: CD012066, 2023.
14.	Kata Y, Hara Y, Murohashi K, Saigusa Y, Nagasawa R, Tagami Y, Fujii H, Aoki A, Nishikawa Y, Tanaka K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: ＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia. Nagoya J Med Sci, 85: 302-611, 2023.
15.	Chen H, Yumoto K, Kashizaki F, Koizumi H, Ikeda I, Horita N, Takahashi K, Kaneko T: KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer. Transl Lung Cancer Res, 12: 1830-1833, 2023.
16.	Hirama N, Yamamoto M, Nagaoka S, Segawa W, Sugimoto C, Nagayama H, Hiro S, Kajita Y, Maeda C, Kubo S, Seki K, Nagahara Y, Teranishi S, Tashiro K, Hara Y, Kobayashi N, Watanabe S, Kudo M, Kaneko T: Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma. Thorac Cancer, 14: 2601-2607, 2023.
17.	Hamakawa Y, Agemi Y, Shiba A, Ikeda T, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Nakamura Y, Shimokawa T, Saigusa Y, Kobayashi N, Okamoto H, Kaneko T: Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC. Cancer Med, 12: 17788-17797, 2023.
18.	Matsumoto H, Somekawa K, Horita N, Ueda S, Kaneko M, Kaneko A, Fukuda N, Izawa A, Kamimaki C, Tanaka K, Murohashi K, Fuji H, Tagami Y, Aoki A, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis. Ther Adv Med Oncol, 15: 17588359231198453, 2023.
19.	Aoki A, Hara Y, Fujii H, Murohashi K, Nagasawa R, Tagami Y, Enomoto T, Matsumoto Y, Masuda M, Watanabe K, Horita N, Kobayashi N, Kudo M, Ogura T, Kaneko T: The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study. PLoS One, 18: e0291489, 2023.
20.	Masumoto N, Kato S, Aichi M, Hasegawa S, Sahara K, Suyama K, Sano A, Miyazaki T, Okudela K, Kaneko T, Takahashi T: AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines. Thorac Cancer, 14: 2897-2908, 2023.
21.	Kajita Y, Teranishi S, Sawazumi T, Watanabe H, Nagaoka S, Tanaka A, Suzukawa Y, Motobayashi Y, Hirose T, Maeda C, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Inayama Y, Kaneko T: Comparison of the slow-pull and aspiration methods of endobronchial ultrasound-guided transbronchial needle aspiration for next-generation sequencing-compatible tissue collection in non-small cell lung cancer. Cancer Med, 12: 19512-19522, 2023.
22.	Nakamura K, Fujita Y, Chen H, Somekawa K, Kashizaki F, Koizumi H, Takahashi K, Horita N, Hara Y, Muro S, Kaneko T: The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis. Diseases, 11: 152, 2023.
23.	Kobayashi N, Miura K, Kaneko A, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Kudo M, Miyazawa N, Kaneko T: Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes. Cancers (Basel), 15: 5248, 2023.
24.	Nagasawa R, Niwa T, Hagiwara E, Oda T, Yamada S, Okuda R, Baba T, Komatsu S, Kaneko T, Ogura T: Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19. Intern Med, 62: 3125-3130, 2023.
25.	Inoue S, Kata Y, Suido Y, Nakashima K, Otsu Y, Takayasu H, Matsumoto Y, Kaneko T: Limited efficacy of low-dose dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective study. Respir Investig, 61: 760-767, 2023.
26.	Masumoto N, Oshikata C, Nakadegawa R, Motobayashi Y, Osada R, Manabe S, Kaneko T, Tsurikisawa N: Dupilumab suppresses relapsing chronic eosinophilic pneumonia with severe asthma. Nagoya J Med Sci, 85: 857-865, 2023.
27.	Chen H, Kondo M, Horita N, Takahashi K, Kaneko T: The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment. Cancers (Basel), 15: 5346, 2023.
28.	Tanaka M, Oshikata C, Yamashita Y, Isono R, Nakadegawa R, Masumitsu H, Motobayashi Y, Osada R, Takayasu H, Masumoto N, Manabe S, Kaneko T, Ueno A, Tsurikisawa N: Eosinophilic granulomatosis with polyangiitis and severe cardiac involvement in a patient surviving for 34 years. J Asthma, 60: 2233-2242, 2023.
29.	Kubo S, Kobayashi N, Matsumoto H, Somekawa K, Kaneko A, Hashimoto H, Teranishi S, Watanabe K, Horita N, Hara Y, Kudo M, Kaneko T: Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer. J Cancer Res Clin Oncol, 149: 17419-17426, 2023.
30.	Tagami Y, Hara Y, Murohashi K, Nagasawa R, Fujii H, Izawa A, Yabe A, Saigusa Y, Kobayashi M, Shiida M, Hirata M, Otsu Y, Watanabe K, Horita N, Kobayashi N, Kaneko T: Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease. Sci Rep, 13: 22639, 2023.
31.	Watanabe K, Koji O, Matsumura M, Kaneko T: Post-COVID-19 Granulomatous Inflammation in the Lung, Distinct From Sarcoidosis: A Report of Two Cases. Cureus, 15: e50821, 2023.

総説

1.	井澤亜美, 原 悠, 金子 猛: 【咳の診断　これだけ読んで目星をつける】副鼻腔気管支症候群(解説). Allos Ergon, 3: 975-980, 2023.
2.	平田萌々, 原 悠, 金子 猛: 【慢性咳嗽2023】呼吸器疾患における咳嗽のメカニズムと対応　副鼻腔気管支症候群(解説). 呼吸器内科, 44: 67-71, 2023.
3.	芳賀 暁, 宇都宮大輔, 原 悠, 金子 猛: 【症例から学ぶ心臓血管放射線診断】腫瘍　心膜中皮腫(解説). 画像診断, 44: 72-73, 2023.
4.	藤井裕明, 原 悠, 金子 猛: 呼吸器内科専門医講座 呼吸器内科専門医のための模擬テスト7－解答と解説－. 呼吸器内科, 43: 471-474, 2023.

学会発行診療ガイドライン等

1.	金子 猛(作成委員): 日本呼吸器学会: 難治性喘息診断と治療の手引き〔第2版〕2023, メディカルレビュー社, 2023.
2.	金子 猛(作成委員): 日本喘息学会: 喘息診療実践ガイドライン2023, 協和企画, 2023.

著書

1.	金子 猛: 喘息・COPDオーバーラップ(ACO). 今日の治療指針2023. 医学書院, 295-297, 2023.
2.	金子 恵, 原 悠, 金子 猛: 慢性閉塞性肺疾患（COPD）. シーン別 内科病棟頻用薬の使い方. 日本医事新報社, 117-122, 2023.
3.	藤井裕明, 原 悠, 金子 猛: 去痰薬・鎮咳薬の選び方・用い方. 喘息・COPDと気道疾患包括診療マニュアル. 中外医学社, 98-109, 2023.

シンポジウム・教育講演等

1.	小林信明: ＜ランチョンセミナー＞LTBIスクリーニングの最新の知見－免疫不全を伴う高リスク症例におけるLTBI診療の現状と課題－. 第98回日本結核・非結核性抗酸菌症学会学術講演会, 東京, 2023, 6.
2.	金子 猛: ＜特別講演＞「咳嗽・喀痰診療ガイドライン2024」. 第25回日本咳嗽学会学術大会, 栃木, 2023, 9.
3.	原 悠: ＜シンポジウム＞重症喘息における気道粘液栓の臨床的意義. 第72回日本アレルギー学会学術大会, 東京, 2023, 10.
4.	金子 猛: ＜特別講演＞喘息および COPD の病態理解のパラダイムシフト中枢気道粘液栓について. 第91回日本呼吸器学会・日本結核 非結核性抗酸菌症学会・ 日本サルコイドーシス／肉芽腫性疾患学会 九州支部秋季学術講演会, 宮崎, 2023, 10.